Showing results (141-150 of 260) with videos related to

Sort By:
Pageof 26
Antibiotics (Basel, Switzerland)|December 23, 2023
Which Are the Best Regimens of Broad-Spectrum Beta-Lactam Antibiotics in Burn Patients? A Systematic Review of Evidence from Pharmacology StudiesGianpiero Tebano, Giulia la Martire, Luigi Raumer, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|May 8, 2026
ARC in Critical Ill OLT Recipients: True Prevalence, Risk Factors, and Impact on Early Aggressive PK/PD Target Non-Attainment of CI Beta-Lactam Therapy for Posttransplant Gram-Negative InfectionsMilo Gatti, Riccardo De Paola, Matteo Rinaldi, et al.
Antibiotics (Basel, Switzerland)|August 28, 2025
TDM-Based Approach for Properly Managing Intravenous Isavuconazole Treatment in a Complex Case Mix of Critically Ill PatientsMilo Gatti, Matteo Rinaldi, Riccardo De Paola, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 24, 2004
Linezolid disposition after standard dosages in critically ill patients undergoing continuous venovenous hemofiltration: a report of 2 casesFederico Pea, Pierluigi Viale, Manuela Lugano, et al.
Antimicrobial Agents and Chemotherapy|December 16, 2015
Does Critical Illness Change Levofloxacin Pharmacokinetics?Jason A Roberts, Menino Osbert Cotta, Piergiorgio Cojutti, et al.
British Journal of Clinical Pharmacology|November 23, 2025
Can a population pharmacokinetics model built on intermittent infusions accurately predict meropenem concentrations in children receiving continuous infusions?Lucy Cheng, Suchita Kumar, Pier Giorgio Cojutti, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 25, 2022
Linezolid Population Pharmacokinetics to Improve Dosing in Cardiosurgical Patients: Factoring a New Drug-Drug Interaction PathwayManjunath P Pai, Pier Giorgio Cojutti, Valentina Gerussi, et al.
Pageof 26